Single-cell Omics Market Growth, Size, Trends, Demand, Revenue, Challenges and Future Outlook
Single-cell Omics Market Size- Product, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Oct-2023 | Report ID: HLCA2364 | Pages: 1 - 234 | Formats*: |
| Category : Healthcare | |||
Single-cell Omics Market Introduction and Overview
According to SPER Market Research, the Global Single-cell Omics Market is estimated to reach USD 18.67 billion by 2033 with a CAGR of 20.42%.
The report includes an in-depth analysis of the Global Single-cell Omics market, including market size and trends, product mix, distribution channels, and supplier analysis. The Single-cell omics is an emerging area of study that looks at individual cells to acquire a better knowledge of cellular processes, heterogeneity, and disease pathology. Single cell genome-wide techniques offer a valuable chance to test many substances with high precision, such as DNA, RNA, protein, and chromatin. We may develop a multi-omics profile for the same cell using these several single cell omics profiling methodologies as building pieces. High-throughput technology development
- BioExcel Diagnostic tools and Takara Bio USA, Inc., innovation life science reagent and device businesses, are developing and validating a current high and comprehensive technique for diagnosing infectious diseases based on syndromic markers. Takara Bio USA, Inc. is a wholly owned subsidiary of Takara Bio Inc.
- QIAGEN and Neuron23 Inc., an initial biotechnology company dedicated to developing precision medications for genetic neurological and immunological diseases, announced the signing of an agreement to create a partner screening for Neuron23's brain penetrant, blocker for Parkinson's disease.
Market Opportunities and Challenges
Opportunities: Single-cell omics can aid in the identification of biomarkers for illness diagnosis, prognosis, and treatment response. This could lead to the creation of new diagnostic tests and medicines. Single-cell omics can assist uncover new pharmacological targets and pathways, as well as analyze medication efficacy and toxicity. This could lead to the development of more effective and safer medications. Single-cell omics can assist improve crop productivity and quality, as well as food safety and traceability.
Challenges: The common difficulty that makes this market hard is sample preparation and cell reproducibility. High infrastructure costs - because technology, databases, and equipment are all highly expensive to purchase. As a result, it presents a significant barrier to entry for newly formed businesses seeking to compete with market giants. The cost of equipment and technology can only be justified if the professionals who will use them are available, which is another significant hurdle in the Single cell omics market. Clinical regulations in the application of single cell omics are extremely important and can complicate the entire procedure.
Market Competitive Landscape
The market for Single-cell Omics is extremely consolidated. 10X Genomics, Inc, 1CellBio, BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc, Celsee, Inc, Fluxion Biosciences, GE LifeSciences, Illumina, Inc, Mission Bio, and QIAGEN N.V. Some of the market key players in global Single-cell Omics market.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | Product, By Application, By End User |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | 10X Genomics, Inc, 1CellBio, BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc, Celsee, Inc, Fluxion Biosciences, GE LifeSciences, Illumina, Inc, Mission Bio, and QIAGEN N.V. |
COVID-19 Impact on Global Single-cell Omics Market
The development of the COVID-19 pandemic boosted the single-cell omics market. As the globe faced a historic health crisis, researchers and scientists resorted to single-cell omics technologies as effective tools for unraveling the complexity of the SARS-CoV-2 virus and its consequences on the human body. These technologies were critical in assessing immune responses, finding biomarkers, and evaluating illness causes, supplementing market trends. Furthermore, single-cell omics aided in the rapid creation of targeted antiviral therapies and vaccines by offering insights into the virus's complicated interactions with host cells. Furthermore, the increasing focus and financing for COVID-19 research sparked innovation in single-cell omics platforms, making them more accessible, efficient, and scalable.
Key Target Audience:
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutions
- Clinical Laboratories and Diagnostics Companies
- Biomedical Researchers
- Government and Regulatory Agencies
- Investors and Venture Capital Firms
- Healthcare Providers
- Genomic Service Providers
- Bioinformatics and Data Analysis Providers
Our in-depth analysis of the Single-cell Omics Market includes the following segments:
| By Product: |
|
| By Application: |
|
| By End Use: |
|
Key Topics Covered in the Report:
- Global Single-cell Omics Market Size (FY’2023-FY’2033)
- Overview of Global Single-cell Omics Market
- Segmentation of Global Single-cell Omics Market By Product (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics)
- Segmentation of Global Single-cell Omics Market By Application (Oncology, Cell Biology, Neurology, Immunology)
- Segmentation of Global Single-cell Omics Market By End User (Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Others)
- Statistical Snap of Global Single-cell Omics Market
- Expansion Analysis of Global Single-cell Omics Market
- Problems and Obstacles in Global Single-cell Omics Market
- Competitive Landscape in the Global Single-cell Omics Market
- Impact of COVID-19 and Demonetization on Global Single-cell Omics Market
- Details on Current Investment in Global Single-cell Omics Market
- Competitive Analysis of Global Single-cell Omics Market
- Prominent Players in the Global Single-cell Omics Market
- SWOT Analysis of Global Single-cell Omics Market
- Global Single-cell Omics Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Global Single-cell Omics Market
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Single-cell Omics Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Single-cell Omics Market
7. Global Single-cell Omics Market, By Product (USD Million)
7.1. Global Single-cell Omics Market Value Share and Forecast, By Product, 2023-20337.2. Single Cell Genomics7.3. Single Cell Proteomics7.4. Single Cell Transcriptomics7.5. Single Cell Metabolomics
8. Global Single-cell Omics Market , By Application (USD Million)
8.1. Global Single-cell Omics Market Value Share and Forecast, By Application, 2023-20338.2. Oncology8.3. Cell Biology8.4. Neurology8.5. Immunology8.6. Others
9. Global Single-cell Omics Market , By End Use (USD Million)
9.1. Global Single-cell Omics Market Value Share and Forecast, By End Use, 2023-20339.2. Academic & Research Laboratories9.3. Biotechnology & Pharmaceutical Companies9.4. Hospitals & Diagnostic Laboratories9.5. Others
10. Global Single-cell Omics Market Forecast, 2019-2033 (USD Million)
10.1. Global Single-cell Omics Market Size and Market Share
11. Global Single-cell Omics Market, By Product, 2019-2033 (USD Million)
11.1. Global Single-cell Omics Market Size and Market Share By Product (2019-2026)11.2. Global Single-cell Omics Market Size and Market Share By Product (2027-2033)
12. Global Single-cell Omics Market, By Application, 2019-2033 (USD Million)
12.1. Global Single-cell Omics Market Size and Market Share By Application (2019-2026)12.2. Global Single-cell Omics Market Size and Market Share By Application (2027-2033)
13. Global Single-cell Omics Market, By End User, 2019-2033 (USD Million)
13.1. Global Single-cell Omics Market Size and Market Share By End User (2019-2026)13.2. Global Single-cell Omics Market Size and Market Share By End User (2027-2033)
14. Global Single-cell Omics Market, By Region, 2019-2033 (USD Million)
14.1. Global Single-cell Omics Market Size and Market Share By Region (2019-2026)14.2. Global Single-cell Omics Market Size and Market Share By Region (2027-2033)14.3. Asia-Pacific14.3.1. Australia14.3.2. China14.3.3. India14.3.4. Japan14.3.5. South Korea14.3.6. Rest of Asia-Pacific14.4. Europe14.4.1. France14.4.2. Germany14.4.3. Italy14.4.4. Spain14.4.5. United Kingdom14.4.6. Rest of Europe14.5. Middle East and Africa14.5.1. Kingdom of Saudi Arabia14.5.2. United Arab Emirates14.5.3. Rest of Middle East & Africa14.6. North America14.6.1. Canada14.6.2. Mexico14.6.3. United States14.7. Latin America14.7.1. Argentina14.7.2. Brazil14.7.3. Rest of Latin America
15. Company Profile
15.1. 10X Genomics, Inc15.1.1. Company details15.1.2. Financial outlook15.1.3. Product summary15.1.4. Recent developments15.2. 1CellBio15.2.1. Company details15.2.2. Financial outlook15.2.3. Product summary15.2.4. Recent developments15.3. BGI Genomics Co. Ltd15.3.1. Company details15.3.2. Financial outlook15.3.3. Product summary15.3.4. Recent developments15.4. Bio-Rad Laboratories, Inc15.4.1. Company details15.4.2. Financial outlook15.4.3. Product summary15.4.4. Recent developments15.5. Celsee, Inc15.5.1. Company details15.5.2. Financial outlook15.5.3. Product summary15.5.4. Recent developments15.6. Fluxion Biosciences15.6.1. Company details15.6.2. Financial outlook15.6.3. Product summary15.6.4. Recent developments15.7. GE LifeSciences15.7.1. Company details15.7.2. Financial outlook15.7.3. Product summary15.7.4. Recent developments15.8. Illumina, Inc15.8.1. Company details15.8.2. Financial outlook15.8.3. Product summary15.8.4. Recent developments15.9. Mission Bio15.9.1. Company details15.9.2. Financial outlook15.9.3. Product summary15.9.4. Recent developments15.10. QIAGEN N.V15.10.1. Company details15.10.2. Financial outlook15.10.3. Product summary15.10.4. Recent developments15.11. Takara Bio15.11.1. Company details15.11.2. Financial outlook15.11.3. Product summary15.11.4. Recent developments15.12. Others
16. List of Abbreviations
17. Reference Links
18. Conclusion
19. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Single-cell Omics Market is projected to reach USD 18.67 billion by 2033, growing at a CAGR of 20.42% during the forecast period.
Single-cell Omics Market grew in market size from 2023. The Market is expected to reach USD 18.67 billion by 2033, at a CAGR of 20.42% during the forecast period.
Single-cell Omics Market CAGR of 20.42% during the forecast period.
"You can get the sample pages by clicking the link -Click Here"
Single-cell Omics Market size is USD 18.67 billion from 2023 to 2033.
Single-cell Omics Market Segment is Covered Product, By Application, By End User
The North America region is anticipated to have the highest market share in Single-cell Omics Market.
The key players in the market include Companies Covered 10X Genomics, Inc, 1CellBio, BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc, Celsee, Inc, Fluxion Biosciences, GE LifeSciences, Illumina, Inc, Mission Bio, and QIAGEN N.V.
The Single-cell omics is an emerging area of study that looks at individual cells to acquire a better knowledge of cellular processes, heterogeneity, and disease pathology.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
